Rider, S.; Verlhac-Trichet, V.; Constant, D.; Chenal, E.; Etheve, S.; Riond, B.; Schmidt-Posthaus, Heike; Schoop, R. (2023). Calcifediol is a safe and effective metabolite for raising vitamin D status and improving growth and feed conversion in rainbow trout. Aquaculture, 568, p. 739285. Elsevier 10.1016/j.aquaculture.2023.739285
|
Text
Posthaus_Rider_et_al_Aquaculture_2023.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC). Download (950kB) | Preview |
The vitamin D endocrine system is required for the transcriptional regulation of a myriad of vertebrate genes including those involved in bone health, growth, nutrient metabolism and immunity. The requirements of salmonids for vitamin D are amongst the highest for any aquaculture species. With nuances, the metabolism of the pre-vitamin cholecalciferol (D3) via calcifediol (25-OH-D3), required to produce the physiologically active hormone calcitriol (1,25-OH-D3) is conserved in fish. The composition of modern aquafeeds, growth in seawater and production challenges, such as disease, may result in the suboptimal biochemical activation of vitamin D hormone in fish.
A 91-day experimental feeding trial was used to test the safety and efficacy of calcifediol for the supply of vitamin D to rainbow trout with an initial body weight of 57.6 g. A practical diet containing cholecalciferol within recommended levels (5240 IU) was supplemented with either 69.8, 687 or 6854 μg/kg calcifediol. The efficacy of calcifediol was determined by the assessment of zootechnical performance and the appearance of vitamin D metabolites in the blood. The safety of the dietary interventions was assessed from generic health indices, examination of gross pathologies, hematology, and blood chemistry.
Test fish increased body weight at least 5.6-fold to 323.5 g over the experimental feeding period. The supplementation of 687 or 6854 μg/kg calcifediol resulted in significant improvements in growth rate and feed conversion (FCR). Whilst not detectable in control fish, calcifediol increased linearly according to dietary levels in the blood and to a lesser extent in the white muscle. The increases of calcifediol in the blood were accompanied by saturable increases of circulating active vitamin D. At the end of the 91-day feeding period, survival was 100%, no gross pathologies relating to the diets were observed, and health indices, hematology, and blood chemistry, including calcium and phosphorus, were not significantly altered.
The supplementation of calcifediol to practical diets containing recommended levels of cholecalciferol improves zootechnical performance and ensures that maximal levels of active vitamin D are present in the blood to meet physiological demands. With a lack of significant effects on health indices, hematology, and blood chemistry, including calcium and phosphorus, the tested high doses of calcifediol are concluded to be safe for salmonids.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
05 Veterinary Medicine > Department of Infectious Diseases and Pathobiology (DIP) 05 Veterinary Medicine > Department of Infectious Diseases and Pathobiology (DIP) > Institute for Fish and Wildlife Health (FIWI) |
UniBE Contributor: |
Schmidt-Posthaus, Heike |
Subjects: |
600 Technology > 630 Agriculture 500 Science > 590 Animals (Zoology) |
ISSN: |
0044-8486 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Pamela Schumacher |
Date Deposited: |
29 Mar 2023 10:54 |
Last Modified: |
02 Apr 2023 02:15 |
Publisher DOI: |
10.1016/j.aquaculture.2023.739285 |
BORIS DOI: |
10.48350/180919 |
URI: |
https://boris.unibe.ch/id/eprint/180919 |